BOSTON – JLL announced that Carolyn Wheatley has joined the firm as an Executive Vice President of the brokerage team for tenant representation of biotechnology and technology clients. Wheatley will focus on life sciences in the Greater Cambridge and Boston regions amid ongoing demand in the competitive markets.
As a commercial real estate advisor at JLL, Wheatley will provide consulting and advisory expertise for companies navigating strategic planning and leasing processes. Wheatley specializes in advising early-and expansion-phase biotechnology and technology companies, and her approach involves significant due diligence and support for clients, before, during, and after a lease transaction.
“With over six years representing clients in the Greater Boston region, I know the life science boom is here to stay,” said Wheatley. “And with that, the demand from both tenants and landlord who are seeking to expand their footprint in the market. I’m thrilled to join JLL and be part of a team that truly values its clients and creates rewarding opportunities for employees and communities alike.”
“The growing demand for biotechnology space in the region has created tremendous opportunities for clients and workforce development too,” said Matt Daniels, New England Brokerage Lead and Executive Managing Director at JLL. “Wheatley is a rising star positioned among the many advisors leading the way in life sciences and commercial real estate. We are very lucky to have her on our team and look forward to leveraging her expertise.”
Wheatley previously worked at CBRE Inc. where she served as a Senior Vice President specializing in tenant and landlord representation in the Cambridge and Boston life sciences markets. In 2019, Wheatley was honored with the Commercial Brokers Association (CBA)’s Rising Star Award.
JLL data shows Life Science demand in the region is now twice pre-COVID levels, and funding has tripled, making Cambridge the epicenter of the most dynamic life sciences innovation market in the world that continues to attract the current and next generation of life science leaders.
